HUMANE KARDIOVASKULÄRE VORLÄUFERZELLEN

European patent · EP2273996 · In force

Register entry

Publication number
EP2273996
Application number
EP09726362
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 25, 2009
Published
Jan 19, 2011
Granted
Feb 22, 2017
Protection ends at the latest
Mar 24, 2029
Next annual fee due
Mar 31, 2027
IPC classes
C12N 5/077 (2010.01)
A61K 35/12 (2015.01)
A61P 9/00 (2006.01)
Priority
US 40049 27.03.2008
PCT application
PCT/US2009/038220 25.03.2009
PCT publication
WO2009/120762 01.10.2009
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Apr 2, 2024

    Change

    Published in Swissreg on 02.04.2024

  4. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  5. Sep 22, 2021

    Transferred

    Owner
    Mount Sinai School of Medicine of New York, University, One Gustave L. Levy Place, Box 1675, New York, NY 10029, USA → Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, Box 1675, New York, NY 10029-6574, USA

    Published in Swissreg on 22.09.2021

  6. Feb 22, 2017

    Granted

    Published in Swissreg on 22.02.2017

Parties

Holder

Icahn School of Medicine at Mount Sinai

One Gustave L. Levy Place Box 1675, New York, NY 10029-6574, US

Inventor

KELLER, Gordon

Toronto Ontario M4W 2E6, CA

YANG, Lei

New York, NY 10029, US

KATTMAN, Steven

Toronto Ontario M4W 1P1, CA

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.